FDA Inspection 1110723 — Kenji Ando, M.D.
The FDA completed an inspection of Kenji Ando, M.D. on October 31, 2019 in Kitakyushu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 31, 2019
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Kitakyushu (Japan)
Additional Details
Clinical Investigator (CI)